Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Metabolomics in the Study of Disease"
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Frontiers in Metabolomics".
Deadline for manuscript submissions: closed (30 August 2019) | Viewed by 36844
Special Issue Editor
Interests: metabolomics; mass spectrometry; bioanalytical chemistry; method development; disease biomarkers; cancer metabolism; bioinformatics
Special Issue Information
Metabolomics can be used to investigate complex diseases that affect modern society including diabetes, dementia, heart disease, and cancer. Such diseases are often associated with, and characterised by, genetic mutations, but downstream metabolic consequences are not always well understood. Metabolomics has the potential to elucidate changes in cellular metabolism that may not be predictable from genetics but that present a cellular phenotype where therapeutic interventions can have selective and targeted effects. New metabolomics methods and applications, which help us gain insight into the complexities of the disease metabolome, are of particular relevence. In this Special Issue of Metabolites, we will demonstrate current developments and applications for diagnosis, understanding mechanisms, and finding new treatments for disease.
Dr. James McCullagh
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Using metabolomics to elucidate cellular metabolism in disease.
- Monitoring disease progression and treatment by metabolomics or multi-omics.
- Prognostic and diagnostic metabolite markers of disease.
- Elucidating metabolic pathways in disease states.
- Understanding the metabolic effects of drugs and treatments.
- New analytical methods for monitoring metabolism in disease.